Video
Viral Hepatitis and Liver Disease
26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025
DLT
David L. Thomas
MD
Johns Hopkins School of Medicine, United States
Biography
David Thomas the Stanhope Bayne-Jones Professor of Medicine at the Johns Hopkins School of Medicine. His research is focused on hepatitis C virus (HCV). The interactions between HIV and HCV have been a special research and clinical emphasis. Dr. Thomas has served the National Institutes of Health, Centers for Disease Control and Prevention, American Association of Liver Disease, Infectious Diseases Society of America, the Conference on Retroviruses and Associated Infections, the American Association of Physicians and the associated biomedical journals in multiple leadership/editorial capacities. Dr. Thomas is a member of ASCI (2001), AAP (2011), and received the Society Citation Award from Infectious Diseases Association of America (2014).
RELATED MATERIALS
RELATED COURSES
HIV
HIV
NTD
RSV
Tuberculosis
Viral Hepatitis and Liver Disease
60 min
Steve Taylor, Alfredo Tagarro, David L. Thomas
CME Series | Advances in Clinical Pharmacology of Infectious Diseases
This module offers a focused overview of optimal antiviral therapy - HIV PEP, monoclonal antibodies in pediatric infectious diseases, and future directions in HCV. Topics include drug–drug interactions, pharmacokinetics and pharmacodynamics, dosing in under-represented populations, post-marketing safety, and regulatory considerations.
What Will Set You Apart?
After following this educational series, participants will be able to:
- Summarize key guidelines and challenges in HIV PEP
- Describe the role of monoclonal antibodies in pediatric infectious diseases
- Outline emerging treatment directions for HCV
Is This Program for You?
This program is designed for clinical pharmacologists, pharmacists, clinicians, researchers, postgraduate students, and others engaged in the clinical pharmacology of antiviral therapy.
What Will You Cover in This Module?
- HIV PEP in Clinical Practice
- Monoclonal Antibodies in Pediatric Infectious Diseases
- What Is Next for HCV?